STELLATE THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 Feb 2023)
What this means for you
This application is over — abandoned 27 Feb 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88760517
- Mark type
- Stylized text
- Filed
- 15 Jan 2020
- Published for opposition
- 26 May 2020
- Abandoned
- 27 Feb 2023
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations and therapeutics for the treatment of neurodegenerative diseases and disorders, neurological diseases and disorders, microbiome-related conditions, diseases and disorders related to the gut-brain axis, Alzheimer's disease, Parkinson's disease, Ataxia, Huntington's disease, and amyotrophic lateral sclerosis (ALS)
Owner
- STELLATE THERAPEUTICS INC., NEW YORK, NY, US
- STELLATE THERAPEUTICS INC., New York, NY, US
- Amabiotics Inc., New York, NY, US
- Amabiotics Inc., New York, NY, US
Prosecution history
- 27 Feb 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 27 Feb 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 09 Jul 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jul 2022 — SOU EXTENSION 4 GRANTED
- 07 Jul 2022 — SOU EXTENSION 4 FILED
- 07 Jul 2022 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2022 — CORRECTED NOA E-MAILED
- 03 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Mar 2022 — SOU EXTENSION 3 GRANTED
- 21 Jan 2022 — SOU EXTENSION 3 FILED
- 02 Mar 2022 — DIVISIONAL PROCESSING COMPLETE
- 21 Jan 2022 — DIVISIONAL REQUEST RECEIVED
- 21 Jan 2022 — TEAS REQUEST TO DIVIDE RECEIVED
- 21 Jan 2022 — SOU TEAS EXTENSION RECEIVED
- 16 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED